Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project.
Authors
Kerr, KDafni, U
Schulze, K
Thunnissen, E
Bubendorf, L
Hager, H
Finn, S
Biernat, W
Vliegen, L
Losa, J
Marchetti, A
Cheney, R
Warth, A
Speel, E
Blackhall, Fiona H
Monkhorst, K
Jantus Lewintre, E
Tischler, V
Clark, C
Bertran-Alamillo, J
Meldgaard, P
Gately, K
Wrona, A
Vandenberghe, P
Felip, E
De Luca, G
Savic, S
Muley, T
Smit, E
Dingemans, A
Priest, L
Baas, P
Camps, C
Weder, W
Polydoropoulou, V
Geiger, T
Kammler, R
Sumiyoshi, T
Molina, M
Shames, D
Stahel, R
Peters, S
Affiliation
Department of Pathology, Aberdeen Royal Infirmary, AberdeenIssue Date
2017-11-23
Metadata
Show full item recordAbstract
Reported prevalence of driver gene mutations in non-small cell lung cancer (NSCLC) is highly variable and clinical correlations are emerging. Using NSCLC biomaterial and clinical data from the ETOP Lungscape iBiobank, we explore the epidemiology of mutations and association to clinicopathological features and patient outcome (relapse-free survival, time-to-relapse, overall survival).Citation
Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project. 2017 Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx629PubMed ID
29186353Type
ArticleLanguage
enISSN
1569-8041ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx629
Scopus Count
Collections
Related articles
- Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
- Authors: Bubendorf L, Dafni U, Schöbel M, Finn SP, Tischler V, Sejda A, Marchetti A, Thunnissen E, Verbeken EK, Warth A, Sansano I, Cheney R, Speel EJM, Nonaka D, Monkhorst K, Hager H, Martorell M, Savic S, Kerr KM, Tan Q, Tsourti Z, Geiger TR, Kammler R, Schulze K, Das-Gupta A, Shames D, Peters S, Stahel RA, Lungscape Consortium.
- Issue date: 2017 Sep
- A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.
- Authors: Kerr KM, Thunnissen E, Dafni U, Finn SP, Bubendorf L, Soltermann A, Verbeken E, Biernat W, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Radonic T, Wilson J, De Luca G, Gray SG, Cheney R, Savic S, Martorell M, Muley T, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dziadziuszko R, Vansteenkiste J, Weder W, Polydoropoulou V, Geiger T, Kammler R, Peters S, Stahel R, Lungscape Consortium.
- Issue date: 2019 May
- Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
- Authors: Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P
- Issue date: 2009 Jan
- Relationship between driver gene mutations, their relative protein expressions and survival in non-small cell lung carcinoma in Macao.
- Authors: Chan KI, Vong HT, Sin LF, Yip YC, Zhong XY, Wen JM
- Issue date: 2018 Apr
- Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.
- Authors: Li S, Li L, Zhu Y, Huang C, Qin Y, Liu H, Ren-Heidenreich L, Shi B, Ren H, Chu X, Kang J, Wang W, Xu J, Tang K, Yang H, Zheng Y, He J, Yu G, Liang N
- Issue date: 2014 May 27